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Ryanodine receptors are ion channels that allow for the release of Ca2+ from the endoplasmic or sarcoplasmic reticulum. They 
are expressed in many different cell types but are best known for their predominance in skeletal and cardiac myocytes, where 
they are directly involved in excitation-contraction coupling. With molecular weights exceeding 2 MDa, Ryanodine Receptors 
are the largest ion channels known to date and present major challenges for structural biology. Since their discovery in the 
1980s, significant progress has been made in understanding their behaviour through multiple structural methods. Cryo-electron 
microscopy reconstructions of intact channels depict a mushroom-shaped structure with a large cytoplasmic region that pre-
sents many binding sites for regulatory molecules. This region undergoes significant motions during opening and closing of the 
channel, demonstrating that the Ryanodine Receptor is a bona fide allosteric protein. High-resolution structures through X-ray 
crystallography and NMR currently cover ~11% of the entire protein. The combination of high- and low-resolution methods 
allows us to build pseudo-atomic models. Here we present an overview of the electron microscopy, NMR, and crystallographic 
analyses of this membrane protein giant. 
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Ryanodine Receptors (RyRs) are high-conductance ion 
channels located in the endoplasmic/sarcoplasmic reticu-
lum (ER/SR). Being permeable to Ca2+, they are involved 
in various physiological events such as learning and 
memory, secretion, fertilization, and apoptosis. Their most 
prominent role is in the contraction of both cardiac and 
skeletal muscle.  
Their name originates from the ability of the channel to 
bind the plant alkaloid ryanodine at nanomolar affinity, 
which locks the channel in subconductance states at low 
concentrations, and blocks them entirely at higher concen-
trations [1]. RyRs are the largest ion channels currently 
known, and form a homotetrameric assemblies measuring 
approximately 2.3 MDa (565 kD/subunit). In mammalian  
organisms, three isoforms have been identified, encoded on 
different chromosomes. RyR1 is the predominant isoform in 
skeletal muscle [2], while RyR2 is enriched in the heart [3]. 
The third subtype (RyR3) was originally identified in the 
brain [4], but all three isoforms are expressed in multiple 
cell types. They share about 70% sequence identity, and the 
sequence deviations mainly stem from three divergent  
regions in the RYR genes, referred to as DR1, DR2, and 
DR3 [5]. 
RyRs are crucial in excitation-contraction (E-C) coupling. 
In myocytes, depolarization of the plasma membrane prop-
agates through invaginations in the sarcolemma (transverse 
tubules or T-tubules), where L-type voltage-gated Ca2+ 
channels (CaVs) are located. The activation of these CaVs by 
membrane depolarization stimulates RyRs in the SR. Thus, 
CaVs act as the voltage sensor for RyRs [6−8]. In skeletal 
muscle, RyR1 and CaV1.1 interact directly [9,10], and this  
mechanical coupling is sufficient for the activation of RyR1. 
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On the other hand, in the cardiac muscle, RyR2 is activated 
by the small influx of extracellular Ca2+ through CaVs in a 
process known as Ca2+-induced-Ca2+ release (CICR). In 
either case, the end result is a massive release of SR Ca2+ 
into the myoplasm through RyRs in response to membrane 
depolarization, leading to muscle contraction. RyRs thus act 
as signal amplifiers, increasing the Ca2+ message originating 
from L-type CaVs. The T-tubules and the SR form very 
close contacts (~12 nm) in junctional sites [11]. In skeletal 
muscle, junctional sites are known as triads, while they 
form dyads in cardiac myocytes [12]. The proximity be-
tween the two membranes allows a rapid and precise com-
munication between the voltage sensor and the signal am-
plifier. 
Mutations in RyRs have been linked to severe disease 
phenotypes, reflecting their importance in the tight regula-
tion of Ca2+ release during muscle contraction [13]. More 
than 200 mutations have been identified in RyR1, and they 
are associated with malignant hyperthermia, central core 
disease, and several other conditions. In the cardiac isoform, 
more than 150 mutations have been linked to catechola-
minergic polymorphic ventricular tachycardia (CPVT)  
and arrhythmogenic right ventricular dysplasia type 2 
(ARVD2), two conditions that can lead to sudden cardiac 
death [14,15]. 
The RyR provides a platform for an abundance of small 
molecules and protein binding partners, and this is the likely 
reason for the enormous size of this protein [16−21]. These 
include, but are not limited to, Ca2+, calmodulin, FK506- 
binding proteins (FKBPs), calsequestrin, PKA, and CaMKII. 
The size of this modulatory complex can be up to 7 MDa [17]. 
The presence of RyRs in the SR has been observed more 
than 40 years ago, long before their identification. In elec-
tron microscopic images, regularly spaced electron-dense 
protrusions were observed extending from the SR mem-
brane and spanning the gap in the triads [22]. Not knowing 
the identity of these structures as Ca2+ release channels at 
the time, these protrusions were later referred to as “feet” 
structures [23]. Since then, multiple studies have generated 
3-dimensional structures of RyRs, which has provided a 
wealth of information on the molecular mechanisms under-
lying these complex channels. 
In this review, we focus on the progress of select studies 
that provide direct structural information on RyRs, includ-
ing cryo-electron microscopy (cryo-EM), NMR, and X-ray 
crystallography. Many additional methodologies, such as 
FRET, have provided key structural information on the RyR 
architecture, but this is beyond the scope of this review. 
1  Cryo-EM studies of closed RyRs 
Knowing the atomic details of a macromolecular assembly 
greatly enhances our insights into a particular protein. Un-
fortunately, RyRs present major challenges to techniques 
such as X-ray crystallography because of its enormous size, 
its integral membrane protein nature, and dynamic features 
that result in a heterogeneity of functional states. For this 
reason, electron microscopy of single particles and two- 
dimensional crystals has been the primary method of choice 
in the field for many years. 
The presence of junctional “feet” structures has been ob-
served almost half a century ago in thin-section or negative 
stain electron microscopic images. In these studies, images 
captured square-shaped, electron-dense protrusions from the 
SR membrane from both native muscle tissues and isolated 
SR vesicles. For a limited set of examples, see references 
[9,22−28]. The feet were shown to be composed of four 
subunits [29], and their identity was confirmed when elec-
tron microscopic images of purified RyRs were able to 
show the characteristic “feet” structures [30].  
An intriguing property of RyRs is their ability to form 
two-dimensional arrays. It was observed in native tissue 
preparations that skeletal muscle RyRs form checker-
board-like lattices, touching the neighbouring molecules 
near the corners [11,29,31]. It was later found that this is an 
intrinsic property, as purified RyR1 was able to assemble 
into similar patterns and could form two-dimensional crys-
tals [32,33]. In skeletal muscle preparations, tetrads of CaVs 
were found to coincide with the cytoplasmic region of 
RyR1 in an alternating fashion. This strongly suggested that 
the two membrane proteins, each being part of different 
membranes, physically interact [9]. The functional implica-
tions of the clustering and RyR1-CaV interaction will not be 
discussed here but are reviewed elsewhere [6,13,19,34]. 
Numerous efforts have been made to improve the struc-
tural details of RyRs in the electron micrographs. Due to its 
high abundance in the SR membrane and the relative ease of 
purification, the RyR1 structure has been the most inten-
sively studied. One group obtained the 37 Å-resolution 
structure of RyR1 by generating computer-averaged images 
from multiple negative stain images [31,35]. The resolution 
was further improved to ~30 Å by the use of frozen-    
hydrated sample preparations in cryo-electron microscopy 
(cryo-EM) [36−38]. By this time, enough details were pre-
sent to identify globular-shaped domains in the cytoplasmic 
region of the channel. Further description was given to the 
RyR structure: regions found at the corners were termed 
“clamps” as they resembled the shapes of laboratory clamps, 
whereas the regions that connected these corners were 
termed “handles” [38] (Figure 1). 
Comparison between the structures of the three isoforms 
showed that the overall features are universal among the 
subtypes, which is not surprising given their high sequence 
homology [39−42]. The most striking trait of the RyR is its 
mushroom shape, composed of two parts: a larger cyto-
plasmic region forming the cap (~80%) and a smaller 
transmembrane region forming the stem (~20%). Both form 
square prisms that are rotated by ~40° relative to one anoth-
er, and which are connected via four thick columns ~14 Å  
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Figure 1  Cryo-EM of closed RyR. The 9.6 Å map (EMDB accession 
code 1275) of closed RyR1 [43] showing A. a view from the cytoplasm 
facing the SR and B. from the side in the plane of the SR membrane. Sub-
regions are labelled according to [44], with some alternatives according to 
[45] shown in brackets. All cryo-EM images, unless mentioned otherwise,  
were prepared using the software package “UCSF Chimera” [146]. 
long. The transmembrane region measures 120 × 120 × 60 
Å3, whereas the cytoplasmic foot measures approximately 
270 × 270 × 100 Å3. The latter portion contains numerous 
globular masses and a series of cavities in which more than 
50% of its volume is occupied by solvent. Fifteen globular 
subregions have been identified so far and arbitrarily as-
signed. Based on segmentation of the highest resolution 
map [43,44] (Figure 1), these subregions can be divided into 
four units: (i) clamps at each corner (subregions 5, 6, 7a, 7b, 
8a, 8b, 9, and 10); (ii) handles connecting two clamp re-
gions (subregions 3 and 4); (iii) a central rim on the cyto-
plasmic face around the fourfold symmetry axis (subregions 
1, 2a, and 2b); and (iv) columns (subregions 11 and 12) that 
connect the cytoplasmic and transmembrane regions. Some 
of the subregions have received alternative labelling (Figure 
1, brackets) [45]. The subunit boundary between each 
monomer was proposed to center around the handle region, 
containing one whole handle, two halves of the clamp re-
gions on either side, and a quarter of the central rim [44], 
although there are some discrepancies which will be dis-
cussed in a later section of this review.  
The major difference between RyR1 and RyR2 seems to 
be located in the clamp region, where some masses were 
found to be either larger or smaller in RyR2 than in RyR1 
[39]. Similarly, comparison between RyR1 and RyR3 has 
revealed extra mass in RyR1 that is missing in RyR3 [42]. 
These structural differences likely contribute to distinct 
functional properties among the three isoforms. 
A key question surrounding RyR structure is the trans-
membrane region. How many helices are present, and what 
is the architecture of the pore-forming part? In order to an-
alyze the transmembrane assembly, the quality and resolu-
tion of the maps are of key importance. Two groups have 
described the structures of closed RyR1 at resolutions near 
1 nanometer, with reported resolutions of 10.2–10.3 Å 
[45,46] and 9.6 Å [43]. It is noteworthy that both studies 
used different criteria to report the resolution (Fourier shell 
correlation or FSC cutoff 0.15 versus 0.5, respectively), 
adding to the debate of which criterion should be used 
[47−49]. 
The highest resolution currently available for any 
full-length RyR is at 9.6 Å (FSC 0.5) for the closed state of 
RyR1 [43]. At this resolution, five putative membrane- 
spanning α helices in each subunit could be assigned inside 
rod-like densities. However, there are likely more secondary 
structure elements, and it has been suggested that each sub-
unit contains 6 or 8 transmembrane helices [50]. Two out of 
the five putative helices (simply named helices 1 and 2) are 
located near the 4-fold central axis and resemble the 
pore-lining and pore helix structures observed in potassium 
channels (Figure 2). Helix 1 is about 45 Å long and is 
kinked, bending away from the 4-fold symmetry axis. At 
the SR luminal side, helices 1 from each subunit together 
form a large, funnel-like cavity with a diameter of approxi-
mately 30 Å, which likely forms the channel entrance. The 
funnel tapers towards the SR membrane, and the narrowest 
part measures about 15 Å in diameter. Helix 1 is the likely 
candidate for the inner, pore-lining helix. Helix 2 is shorter 
(~22 Å) and is tilted about 50° with respect to the plane of 
the SR membrane. Helices 2 from each subunit point to-
wards the 4-fold central axis to form an opening of ~7 Å, 
and are therefore prime candidates for the pore helices. Pu-
tative helices 3, 4 and 5 have lengths of about 18–22 Å. 
Because crystal structures are now available for the pore 
region of several potassium channels, the helical arrange-
ment can be compared directly with the presumed pore- 
forming region in the cryo-EM reconstructions. Although 
the 9.6 Å cryo-EM reconstruction is thought to represent 
RyR1 in the closed state, helices 1 and 2 only poorly match 
the helices of the closed KcsA potassium channel struc- 
 
 
Figure 2  The pore-forming region. Close-up of the transmembrane re-
gion in the 9.6 Å closed RyR1 map. The putative helices are outlined. The  
surrounding density is clipped for clarity. 
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ture [51]. Instead, a higher correlation was found for the 
MthK channel in the open conformation. Kinking of the 
inner helices in the MthK channel is thought to open this 
channel [52]. Since helix 1 appears to be bent already, 
kinking of the inner helices in RyRs is likely not sufficient 
for channel opening [43]. A proposed model places a highly 
conserved glycine (G4934) at the hinge position of the inner 
helix, and two rings of negative charges at the luminal and 
cytoplasmic openings of the pore. Such a charge distribu-
tion is commonly observed in cation-selective channels. For 
a limited set of examples see [51,53−57].  
 In contrast with this, different conclusions have been 
reported by Samso and colleagues. In two RyR1 structures 
in the closed state at reported resolutions 10.2–10.3 Å (FSC 
0.15 cut-off), manual docking showed a higher correlation 
between the closed RyR1 and closed KcsA or KirBac1.1 
channels [45,46,51,58]. Therefore, there are discrepancies 
in shape of the transmembrane helices and in the interpreta-
tions of possible modes of channel gating. These may be 
due to overall differences in the conformational purity of 
the samples, or simply differences in resolution (~4 Å of 
difference when the FSC 0.5 criterion is applied to all stud-
ies). As the structures originated from detergent-solubilized 
preparations, it cannot be excluded that there are differences 
depending on sample handling. 
More recently, a feature detection program was used to 
identify secondary structures in the cytoplasmic region us-
ing the 9.6 Å structure of RyR1 [44,59]. The authors identi-
fied 36 putative α helices and seven putative β sheets in the 
cytoplasmic foot. In particular, one putative β sheet is lo-
cated at subregion 12, near the tapered section of the “col-
umn” region. This β sheet may play an important role in the 
gating of the channel since other channels, including Kir 
and HCN2, share β sheets at the same location [58,60−63]. 
2  Opening and closing 
Being such a large protein, it is conceivable that opening 
and closing of the channel is allosterically coupled to the 
large cytoplasmic foot region. The first open structure of 
RyR was obtained by Orlova and colleagues at 30 Å resolu-
tion [64], followed by more structures in the subsequent 
years [42,46,65]. In these studies, the open conformation of 
RyR was stabilized by the presence of Ca2+ and other mod-
ulators, such as ryanodine, PCB95, and ATP homologs.  
The studies all agree that the closed and open RyRs share 
similar overall structures. One obvious difference is a wid-
ening of the central pore upon opening. The authors also 
reported global conformational changes between the two 
states, especially in the clamps and in the transmembrane 
region. Since structural changes occur far away from the 
proposed pore region, RyRs are clearly allosteric proteins, 
and interference with any of the movements is likely to af-
fect channel function. 
The highest resolution available for the open-state RyR 
thus far is at 10.2 Å (FSC 0.143) for RyR1 [46]. The au-
thors used PCB95, a neuroactive compound, to stabilize the 
open state. The largest conformational changes were found 
in the cytoplasmic foot. In the open conformation, subre-
gions 7, 8, 9, and 10 in the clamp move down towards the 
SR membrane by ~8 Å, while subregion 6 moves outwards 
by ~5 Å (Figure 3). In addition, subregion 2 in the central 
rim moves upward towards the T-tubule and outwards away 
from the 4-fold central axis. Thus, the main conformational 
change in the cytoplasmic portion upon opening of the 
channel is an outward movement away from the center. 
Another large structural change was observed in the 
transmembrane region. The authors identified at least six 
membrane-spanning α helices per subunit, based on the 
number of high density segments in the transmembrane re-
gion. Upon opening, the inner helices seem to kink, as the 
bottom halves shift 3 Å upward towards the cytoplasmic 
side, and tilt ~5°, widening the pore. This observation is 
consistent with other studies that reported rotating motions 
in the transmembrane region and compared the opening and 
closing of RyR to that of a camera aperture [42,64,65]. The 
motions in the cytoplasmic and transmembrane regions 
seem to be coupled via the column region, in particular the 
inner branches, which tilt by ~8° upon opening, moving 
their midpoints ~6 Å away from one another [46]. 
Manual docking of K+ channel structures in the open- 
state map showed that the open RyR1 correlates better with 
open K+ channels [46]. However, since there have been in- 
 
 
Figure 3  Opening and closing. A and B, Two different views of superpo-
sitions of closed (gray, EMDB accession code 1606) and open RyR1 maps 
(red mesh, EMDB accession code 1607). The extent of some conforma- 
tional changes is indicated by arrows. 
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consistent results for correlation between closed RyR1 and 
K+ channel structures [43,45,46], care must be taken when 
interpreting these manual docking results. Although buffer 
conditions can favour an open or closed state in intact 
membranes, this does not necessarily extrapolate to condi-
tions following detergent extraction. As differences in sam-
ple handling may also contribute to structural changes, the 
conformational state is best deduced by analyzing the final 
model rather than assuming a particular state. The discrep-
ancies would be reconciled, for example, if the 9.6 Å RyR1 
structure [43] represents an open or partially open (i.e. sub-
conducting) channel, rather than a fully closed structure.  
Future experiments will undoubtedly shed more light on this 
matter. 
3  Insertion studies 
Despite the continued improvements into the quality of 
full-length RyR structures, the cryo-EM reconstructions are 
of insufficient resolution to locate individual amino acids. 
In the absence of atomic models, one alternative is to de-
termine the rough location of regions of interest via the use 
of antibodies or fusion proteins. In both cases, analysis of 
the difference densities found in cryo-EM reconstructions 
puts restraints on the position of the insertion site or the 
antibody epitope. The residual uncertainties of the locations 
depend on the resolution, the size of the insert or antibody, 
and the lengths of flexible linkers and loops at the insertion 
site. The locations proposed in many of these studies are 
summarized in Figure 4A. 
The three-dimensional localization of the amino terminus 
of RyR has been of great interest since the N-terminal re-
gion (residues 1-614 in RyR1) covers the first of the three 
hot spots for disease mutations. The 34 Å cryo-EM recon-
struction of RyR3, N-terminally fused to GST (GST-RyR3), 
displays an extra mass at the clamp region in the middle of 
subregions 7–10 and a smaller extra mass between subre-
gions 1, 3, and 4 [66]. A 33 Å structure of RyR2 with GFP 
inserted after Ser437 presented additional density between 
subregions 5 and 9 [67]. These studies led the authors to 
conclude that the N-terminal disease hot spot was most 
likely located in the clamp region.  
Another site of interest in the N-terminal region is resi-
dues 590–609 in RyR1 and residues 601–620 in RyR2 
which constitute the proposed binding site for dantrolene 
[68,69]. Dantrolene is the only effective treatment for ma-
lignant hyperthermia, thus knowing the exact location is of 
considerable interest.  Insertions of GFP in the binding site 
did not yield any well-behaved protein, but the 27 Å struc-
ture of RyR2 with GFP inserted after Tyr846 showed a ma-
jor extra mass on the T-tubule side of subregion 9. Along 
with FRET studies, it was concluded that dantrolene also 
binds close to subregion 9, near the binding site for 
FKBP12 [70].  
The central region (residues 2163-2458 in RyR1) har-
bours another disease-mutation hot spot. Insertion of GFP 
near RyR2 Ser2367 showed a significant extra mass in the 
bridging density between subregions 5 and 6 [71]. This ex-
periment suggests that it is possible for the N-terminal and 
central disease hot spots to interact, supporting the zipper- 
hypothesis , which states that the two hot spot regions in-
teract and undergo relative conformational changes upon 
channel opening [72]. 
The three RyR isoforms share about 70% identity, and 
the major sequence differences are located in three stretches 
 
 
Figure 4  Difference cryo-EM. Overview of difference densities observed for fusion proteins and binding partners. Although these studies were performed 
on different RyR isoforms, all are shown here on the RyR1 cryo-EM map to allow a direct comparison. A, View from the cytoplasm  
facing the SR. B, Side view in the plane of the SR membrane. 
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known as divergent regions DR1, DR2, and DR3 [5]. These 
stretches underlie functional differences between the 
isoforms and their three-dimensional location is therefore 
valuable for understanding functional mechanisms in RyRs. 
DR1 is the largest of the three divergent regions and in-
cludes residues 4254−4631 in RyR1 and residues 4210− 
4562 in RyR2. This region is thought to be responsible for 
the varying sensitivities towards Ca2+ inactivation in differ-
ent isoforms [73−75]. One study took advantage of a mono-
clonal antibody raised against residues 4425−4621 [76]. The 
34 Å structure of RyR1 in complex with the antibody 
showed an extra mass in subregion 3. In agreement with this 
observation, an extra mass was observed in the same area 
after inserting GFP at Asp4365 [77].  
The second divergent region, DR2, includes residues 
1342−1403 in RyR1 and residues 1353−1397 in RyR2. This 
region is thought to be involved in E-C coupling [78,79]. 
Interestingly, DR2 is absent in RyR3 [5]. Negative stain 
electron micrographs of RyR1 in presence of an antibody 
against DR2 revealed an extra density in the clamp, close to 
subregion 9 [41]. Consistent with the result, an extra mass 
appeared in subregion 6 in a 34 Å structure of RyR2 with 
GFP inserted after Thr1366 [80]. 
DR3 includes residues 1872−1923 in RyR1 and residues 
1852−1890 in RyR2. This region has been implicated in 
modulation by CaV1.1, Ca
2+, and FKBP [81−83], and is the 
target for some disease mutations [84]. Insertion of GFP 
after RyR2 Thr1874 leads to an extra density in subregion  
9, close to the proposed FKBP12.6 binding site [85]. 
RyRs are the target for phosphorylation by PKA, which 
is known to activate the channels [86,87]. Both Ser2030 and 
Ser2808 are PKA phosphorylation sites [88−90]. The 27 Å 
structure of RyR2 with GFP inserted after Thr2023 showed 
an extra mass in the T-tubule face of subregion 4 [91]. Sim-
ilarly, the 27 Å structure of RyR2 fused to GFP after 
Tyr2801 displayed an extra mass in the bridging density 
connecting subregions 5 and 6 [92]. In agreement, an extra 
mass appeared in the periphery of subregion 6 in the 25Å 
structure of RyR1 in complex with a monoclonal antibody 
raised against residues 2756-2803 (RyR2 residues 2722- 
2769) [92]. One hypothesis concerning the effect of PKA on 
RyR2 is that it causes the dissociation of FKBP12.6, a pro-
tein thought to stabilize the closed state of the channel 
[93−95]. PKA phosphorylation would thus lead to enhanced 
channel opening. However, given the large distance be-
tween the FKBP12.6 binding site (see section below) and 
the presumed position of Ser2808, the authors concluded 
that Ser2808 cannot be directly involved in FKBP12.6 
binding. 
In the absence of atomic-resolution structures for the 
majority of the RyR parts, the use of monoclonal antibodies 
and protein insertions in conjunction with three-dimensional 
reconstructions continue to provide approximate locations 
of RyR components. Care must be taken when interpreting 
the data, as a piece of difference density can also appear 
further away from the insertion site either due to overall 
conformational changes or due to the use of long flexible 
linkers. 
4  The binding sites of protein binding partners 
Using a similar approach, the analysis of difference densi-
ties is very useful to locate the position of RyR binding 
partners (Figure 4B). The differences are either due to the 
binding partner itself, or due to conformational changes that 
arise because of the binding. In contrast to fusion protein 
strategies, such results are not dependent on linker lengths, 
and the confidence about the exact locations is therefore 
much higher.  
FK506-binding proteins (FKBPs), also known as im-
munophilins, bind to RyR1 and RyR2 with high affinities. 
FKBP12, a 12 kD protein as its name suggests, is found 
predominantly in skeletal muscle, where it binds to each 
subunit of RyR1[96]. In the cardiac muscle, FKBP12.6 
preferentially associates with RyR2 [97]. In early studies, 
three-dimensional structures of RyR1-FKBP12 complexes 
at ~35 Å resolution showed that FKBP12 binds between 
subregions 3, 5 and 9 [98,99]. In addition, less significant 
differences were observed in the bridging densities between 
subregions 5 and 6, which could indicate conformational 
changes due to the binding [99]. The location was con-
firmed by a more recent study which showed the structure 
of the RyR1-FKBP12 complex at 16 Å resolution, and 
whereby a crystal structure of FKBP12[100] was docked 
into the difference density [101]. In another recent study, a 
33 Å structure of the RyR2-FKBP12.6 complex highlighted 
a binding site similar to the one for FKBP12 [102]. The 
binding of FKBP12.6 seemed to cause conformational 
changes, as subregion 6 was more extended towards the 
T-tubule and electron dense parts in the transmembrane 
region splayed apart.  
Calmodulin (CaM) binds to RyR1 in both the absence 
(apoCaM) and presence (Ca2+/CaM) of Ca2+. The binding 
site of Ca2+/CaM on RyR1 was first studied using gold- 
cluster labelled CaM[103] and later confirmed by a 37 Å 
RyR1-CaM complex [99]. Ca2+/CaM binds between subre-
gions 3 and 8a, and its association did not seem to cause 
major alterations in the conformation of RyR1. The Ca2+/ 
CaM binding site is approximately 90 Å away from the 
FKBP12 binding site [99]. Similarly, an RyR1-apoCaM 
complex at 28 Å resolution showed that the apoCaM bind-
ing site is located at the outer surface of subregion 3, just 
above the binding site for Ca2+-CaM and closer to the 
T-tubule [104]. These studies suggest that binding of Ca2+ 
can cause one or both CaM lobes to hop from one binding 
site to another, which supports the different functional ef-
fects that Ca2+/CaM and apoCaM have on RyR1 [105−107]. 
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Chloride intracellular channel 2 (CLIC-2) is a protein 
that is widely expressed in skeletal and cardiac muscle of 
vertebrates [108], and which exist in a soluble and mem-
brane-bound form [109]. This 247-residue protein is ho-
mologous to the glutathione-S-transferase (GST) superfam-
ily and was found to inhibit both RyR1 and RyR2 [108,110]. 
A 25 Å structure of the RyR1-CLIC2 complex showed that 
it binds between subregions 5 and 6 [110]. Moreover, 
CLIC- 2 binding seemed to separate subregions 9 and 10, 
resembling the open conformation despite the fact that the 
pore appeared to be closed. 
Being strictly required in E-C coupling and many other 
Ca2+-dependent events, it is not surprising that RyRs are the 
targets of various toxins. Among these is imperatoxin A 
(IpTxa), a 33-residue peptide derived from scorpion venom 
that is known to bind to both RyR1 and RyR2 with high 
affinity, inducing subconductance states [111,112]. Because 
IpTxa is small, it was fused N-terminally to biotin and 
bound to avidin. A 29 Å cryo-EM reconstruction of the re-
sulting complex with RyR1 showed that IpTxa binds in the 
crevice between subregions 3, 7, and 8a [113]. Another 
toxin known to associate with RyRs is natrin, a 221-residue 
protein derived from venom of the snake Naja naja atra. 
Natrin belongs to the cysteine-rich secretory protein (CRISP) 
family and inhibits RyR1 [114]. A 21 Å resolution structure 
of the RyR1-natrin complex showed that the toxin binds 
between subregions 5 and 6 on the surface exposed to the 
cytoplasm [114]. 
5  X-ray crystallography and NMR 
Being giant eukaryotic proteins, RyRs present major chal-
lenges to high-resolution studies. The cryo-EM reconstruc-
tions have shown that the RyR consists of individual globu-
lar regions, which opens up the avenue for high-resolution 
studies of individual RyR domains. To date, six different 
studies have described high-resolution structures of indi-
vidual RyR portions. 
5.1  EF-hand proteins in complex with RyR peptides 
The first high-resolution structures came from a small re-
gion (RyR1 residues 3614-3643) in complex with calmodu-
lin (CaM) [115] and S100A1 [116]. CaM is an EF-hand 
containing protein that can fine-tune the Ca2+-dependent 
feedback to RyRs. For example, at low cytoplasmic Ca2+ 
concentrations, apoCaM potentiates opening of RyR1, 
whereas Ca2+/CaM has been found to inhibit the channel 
[105−107]. In contrast, both apoCaM and Ca2+/CaM seem 
to inhibit RyR2 [117,118]. A 2.0 Å crystal structure of 
Ca2+/CaM in complex with an RyR1 peptide (residues 
3614−3643) was solved by Mackenzie and coworkers [115]. 
The RyR1 peptide forms an α helix, with both lobes of CaM 
binding in an antiparallel arrangement, whereby the N-lobe 
binds to the C-terminal half of the peptide, and the C-lobe 
binds the N-terminal half (Figure 5). The main hydrophobic 
anchors, Trp3620 and Phe3636, have an unusual 1-17 spac-
ing and the CaM lobes therefore do not interact with one 
another. NMR 1H-15N residual dipolar couplings (RDCs) 
suggest that the lobes experience independent domain mo-
tions in solution, such that the RDCs for the two lobes can-
not be fitted simultaneously to the crystal structure. This is 
compatible with the notion that multiple CaM binding do-
mains (CaMBDs) are present within the RyR, and that indi-
vidual lobes may associate with distinct CaMBDs [119,120]. 
Since the cryo-EM showed only one CaM bound per RyR 
monomer, these stretches have to be close for CaM to 
bridge. Given the large number of possible RyR fragments 
that can bind CaM [2,121−123], understanding the binding 
and effects of apoCaM and Ca2+/CaM on RyRs involves 
solving a complex puzzle. 
S100A1 is an EF-hand containing protein from the S100 
protein family. It exists as homodimers, with each monomer 
containing a low- and a high-affinity EF hand. It enhances 
the opening of both RyR1 and RyR2 [124−127]. An NMR 
structure has shown the interaction between Ca2+/S100A1 
and human RyR1 (3616-3627) [116]. Interestingly, some 
residues (including Trp3620) are involved in binding both 
CaM and S100A1, showing that both proteins compete for 
the same binding site. It is therefore possible that the effect 
of S100A1 is due to a competition with CaM: at high Ca2+  
 
 
Figure 5  EF hand containing binding partners. A, Crystal structure of 
Ca2+/CaM (yellow) bound to an RyR1 peptide (blue, residues 3614-3643) 
(PDB accession 2BCX). B, NMR structure of an S100A1 dimer (purple) 
bound to two RyR1 peptides (blue, residues 3616-3627) (PDB accession 
2K2F). Aromatic anchors providing major contacts are indicated (W3620 
and F3636). Red spheres represent Ca2+ ions. All crystal and NMR struc- 
ture figures were prepared using PyMOL (www.pymol.org). 
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levels, S100A1 can compete with Ca2+/CaM and therefore 
abolish its inhibitory effect on the channel. 
5.2  The amino-terminal hot spot 
Both RyR1 and RyR2 have been implicated in a number of 
severe genetic diseases. All together, over 300 different 
point mutations have been associated with these disorders 
[13−15]. Although there may be a significant amount of 
sequencing bias [128], most mutations are found in three 
clusters or “hot spots”. One of these covers the first ~600 
amino acid residues known as the N-terminal disease hot 
spot. Several crystallographic studies have focused on this 
region. The first structure was reported by Ikura and 
coworkers [129], covering the first domain of RyR1 (resi-
dues 1−205). This was soon followed by another study, de-
scribing the same domain in both RyR1 and RyR2 [130]. In 
both studies, the amino-terminal domain (referred to as 
“domain A” from here on) consists of a β-trefoil core, built 
up by twelve β strands, and a single α helix (Figure 6). In 
line with the high degree of sequence conservation, only 
minor differences are present between domains A of RyR1 
and RyR2. Both isoforms contain several disease mutations, 
many of which are located in a loop connecting strands β8 
and β9, also referred to as a HS (hot spot) loop [129]. Nei-
ther NMR nor crystallographic studies of mutant forms of 
this domain showed any significant differences in stability 
or structure [129,130]. Because the mutations appeared to 
be at the surface of domain A, it was assumed that they 
were located at interfaces for other RyR domains or auxil-
iary proteins. 
A recent study has depicted the 2.5 Å crystal structure of 
the first 559 residues of RyR1, a region that covers the bulk 
of the N-terminal hot spot [131]. The hot spot folds up as 3 
independent domains that interact with one another in a 
compact form (Figure 6). Domains A and B both fold up as 
β-trefoil cores, whereas domain C consists of a bundle of 5 
α-helices. The domain-domain interactions are mainly hy-
drophilic in nature and inherently weak. In RyR1 and RyR2 
combined, up to 56 different disease mutations could be 
located on the structure (Figure 6). Fifteen of those are lo-
cated at the interface between domains A, B, and C, and 
seem to destabilize the domain-domain interactions. These 
include mutations that abolish ionic pairs across the do-
mains. Six mutations are buried within individual domains, 
likely causing local misfolding or generally destabilizing 
the protein. All other mutations are found at the periphery 
of the crystal structure. 
A very severe form of CPVT is due to the deletion of a 
35-residue segment (exon 3) in the N-terminal domain of 
RyR2. The deletion ablates an α helix and a β strand that is 
part of the domain A β-trefoil core, but unexpectedly does 
not cause misfolding. Even more surprising is that the dele-
tion enhances the thermal stability of the domain [130]. A  
 
Figure 6  The N-terminal disease hot spot. Crystal structures of RyR1 
domain A (PDB accession 3HSM) (A), highlighting the hot spot (HS) 
loop (purple), RyR2 domain A (PDB accession 3IM5) (B) and RyR1 
domains A, blue; B, green; C, red (PDB accession 2XOA) (C). The posi-
tions of amino acid residues involved in disease (RyR1 and RyR2 com- 
bined) are shown in black. 
recent crystal structure of RyR2 domain A with exon 3 de-
leted highlights a very unusual ‘structural rescue’, whereby 
a flexible loop (exon 4), unique to RyR2, takes over the 
position of the deleted β strand [132]. This observation 
suggests that alternative splicing, allowing either exon 3 or 
exon 4 to insert itself in the β-trefoil core, allows for fine- 
tuning the activity of RyR2. 
6  Pseudo-atomic models 
Cryo-EM images of the entire receptor currently cannot 
locate the positions of individual amino acids. Concurrently, 
high-resolution structures of individual portions provide 
limited information when their locations in the full-length 
proteins are unknown. However, with both techniques com-
bined, it is feasible to start constructing pseudo-atomic 
models, by docking high-resolution fragments into cryo-EM 
maps. 
Several algorithms exist to dock fragments, making use 
of six-dimensional searches (three translational and three 
rotational parameters) along with a scoring function. Crucial 
parameters for a successful experiment include the quality 
and resolution of the cryo-EM reconstruction, and the rela-
tive size of the fragment compared to the intact protein. 
When only small fragments are used, a simple cross-   
correlation coefficient may not suffice to provide a reliable 
position [133,134]. In those cases, it may be advantageous 
720 Kimlicka L, Van Petegem F   Sci China Life Sci   August (2011) Vol.54 No.8 
to make use of a Laplacian filter, which enhances the fea-
tures of the surface. Although the latter may increase high-   
frequency noise, the ideal method for any particular case 
can be identified through a statistical analysis of the correla-
tion coefficients, whereby a correct solution has a correla-
tion coefficient that is significantly higher than the second 
best solution. In the absence of such a docking contrast, the 
reliability of the top solution may be questionable. 
Prior to the availability of high-resolution structures, 
some homology-based models were prepared for the N- 
terminal region, and these were docked in the clamp region 
[44,135]. However, using the crystal structure of the 
N-terminal disease hot spot, a high-contrast solution places 
the N-terminal disease hot spot in the central rim, forming a 
vestibule around the fourfold symmetry axis (Figure 7) [131]. 
Using the segmentation described by [44], domain A occu-
pies subregion 1, whereas domains B and C occupy subre-
gions 2a and 2b, respectively. The different results with  
the prior docking studies are most likely due to discrepan-
cies between the homology based models and the crystal 
structure, and due to the use of different docking algorithms. 
The docking is also at odds with the proposed subunit 
boundaries [44]. 
The hot spot thus seems to form interactions with the 
same region in a neighbouring subunit, mostly involving 
contacts between domains A and B. This interface contains 
the largest concentration of disease mutations (19 so far). A 
side view shows that the hot spot is located far away from 
the transmembrane region, but is connected to the pore- 
forming region via electron dense columns (Figure 7). All 
mutations at the periphery of the disease hot spot were 
found to be located at one of six different interfaces with 
other RyR domains. No mutation was found to be located in 
the exposed surface area, consistent with the fact that no 
protein binding partner has been found in this region.  
The location of the hot spot shows apparent discrepan-
cies with the cryo-EM analysis of fusion proteins containing 
GFP inserted near residue Ser437 in RyR2 [67], or with 
GST fused to the N-terminus of RyR3 [66]. However, when 
the length of the linkers is taken into account, together with 
the inherent length of the loop region containing Ser437, 
these studies can be reconciled [131]. In addition, the 
GST-RyR3 fusion construct displayed two main regions of 
difference density, suggesting the fusion created conforma-
tional changes. One of these is located right next to the 
N-terminus of the docked RyR1ABC domains. 
The cryo-EM studies comparing RyR1 in the open and 
closed states have shown significant movements in the cen-
tral rim where the disease hot spot is located [46]. Together 
with the distribution of the disease mutations, it is plausible 
to assume that most or all of the domain-domain interfaces 
involving the hot spot are labile and subject to movement. 
This creates an energetic penalty to open the channel, 
therefore assigning the role of a ‘brake’ to the hot spot. 
When disease mutations perturb any of these interfaces, the 
energetic penalty is reduced, making it easier for the chan-
nel to open. This is consistent with the fact that most muta-
tions characterized so far lead to a gain of function, including 
increased sensitivity to modulators and leakage of Ca2+ [13]. 
Combining the mutations with another event (increased tem-
perature, binding of halogenated anaesthetics, phosphoryla-
tion, etc.) is then sufficient to open the channels. 
7  Analogies with the inositol-1,4,5-trisphosphate 
receptor (IP3R) 
Inositol-1,4,5-trisphosphate receptors (IP3Rs) are Ca
2+ re-
lease channels, predominantly present in the ER membrane.  
 
 
Figure 7  Pseudo-atomic models. Top view (A) and two side views (90° rotation) (B and C) of the N-terminal disease hot spot docked in the 9.6 Å closed- 
state cryo-EM map. Disease mutations are shown in black, and interfaces with neighbouring RyR domains are labelled. Note: disease mutations in flexible   
loops, mainly located at interface 1, are not shown for clarity. 
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Figure 8  Structural conservation. Superposition of domains A, B, and C 
of RyR1 (PDB accession 2XOA, colored) and IP3R1 (PDB accession  
1XZZ and 1N4K, gray). 
With sizes ~1 MDa, the IP3R is the “little brother” of the 
RyRs, and a significant amount of homology (~30% se-
quence identity) is found for both channels. Not surprisingly, 
a great deal of structural homology is present as well, and 
IP3Rs have been studied by both electron microscopy and 
X-ray crystallography. Several cryo-EM reconstructions of 
IP3Rs have been performed, but since most seem at odds 
with one another, it is difficult at this point to directly com-
pare these with the RyR reconstructions [136−141]. 
Three IP3R domains have been investigated with X-ray 
crystallography. Crystal structures are available for the 
N-terminal suppressor domain (equivalent to domain A) 
[142,143], and for the following two domains (B and C, 
together known as the IP3 binding core) in complex with IP3 
[144]. However, a structure describing all three domains 
together has thus far remained elusive. The RyR1 ABC do-
mains have a surprisingly large amount of structural ho-
mology with the IP3R N-terminal domains, a feature that 
was predicted before the RyR1 ABC crystal structure was 
determined [44]. The secondary structure elements in the 
two β-trefoil domains and the α-helical bundle in domain C 
superpose very well (Figure 8) [145]. The structural con-
servation underlines the evolutionary relationship between 
both channels, and suggests that the interactions between 
the suppressor domain and the IP3 binding core may be very 
similar as well [131,145]. 
8  Conclusion 
The ryanodine receptor is a huge membrane protein for 
which high-resolution has only recently become available. 
Despite a number of studies, only ~11% of the channel has 
been covered at high resolution. Many additional studies 
remain to be done, either filling out all pieces of the 
three-dimensional puzzle with pseudo-atomic models, or 
perhaps a high-resolution structure of the entire edifice. To 
be continued... 
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